Skip to main content
. 2021 Sep 3;35(5):2821–2829. doi: 10.21873/invivo.12569

Table II. Grade 3-4 hematologic adverse events.

graphic file with name in_vivo-35-2825-i0001.jpg

GC-f: Full-dose gemcitabine plus cisplatin; GC-r: reduced-dose gemcitabine plus cisplatin; G-Car-f: full-dose gemcitabine plus carboplatin; G-Carr: reduced-dose gemcitabine plus carboplatin. p-Values were determined by the Chi-square test.